Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Front Immunol. 2019 Feb 19;10:247. doi: 10.3389/fimmu.2019.00247. eCollection 2019.
The surface transferrin receptor proteins from have been recognized as ideal vaccine targets due to their critical role in survival in the human male genitourinary tract. Recombinant forms of the surface lipoprotein component of the receptor, transferrin binding protein B (TbpB), can be readily produced at high levels in the cytoplasm and is suitable for commercial vaccine production. In contrast, the integral outer membrane protein, transferrin binding protein A (TbpA), is produced at relatively low levels in the outer membrane and requires detergents for solubilization and stabilization, processes not favorable for commercial applications. Capitalizing on the core β-barrel structural feature common to the lipoprotein and integral outer membrane protein we engineered the lipoprotein as a scaffold for displaying conserved surface epitopes from TbpA. A stable version of the C-terminal domain of TbpB was prepared by replacing four larger exposed variable loops with short linking peptide regions. Four surface regions from the plug and barrel domains of TbpA were transplanted onto this TbpB C-lobe scaffold, generating stable hybrid antigens. Antisera generated in mice and rabbits against the hybrid antigens recognized TbpA at the surface of and inhibited transferrin-dependent growth at levels comparable or better than antisera directed against the native TbpA protein. Two of the engineered hybrid antigens each elicited a TbpA-specific bactericidal antibody response comparable to that induced by TbpA. A hybrid antigen generated using a foreign scaffold (TbpB from the pig pathogen displaying neisserial TbpA loop 10 was evaluated in a model of lower genital tract colonization by and a model of invasive infection by . The loop 10 hybrid antigen was as effective as full length TbpA in eliminating from the lower genital tract of female mice and was protective against the low dose invasive infection by . These results demonstrate that TbpB or its derivatives can serve as an effective scaffold for displaying surface epitopes of integral outer membrane antigens and these antigens can elicit protection against bacterial challenge.
已经鉴定出,来自 的表面转铁蛋白受体蛋白由于其在男性泌尿生殖道中的生存中起着关键作用,因此是理想的疫苗靶标。受体表面脂蛋白成分的重组形式,转铁蛋白结合蛋白 B(TbpB),可以在细胞质中高水平地容易产生,并且适合商业疫苗生产。相比之下,完整的外膜蛋白,转铁蛋白结合蛋白 A(TbpA)在外膜中以相对较低的水平产生,并且需要去污剂进行溶解和稳定化,这些过程不利于商业应用。利用脂蛋白和完整外膜蛋白共有的核心β-桶结构特征,我们将脂蛋白设计为展示 TbpA 保守表面表位的支架。通过用短连接肽区域替换四个较大的暴露可变环,制备了 TbpB C 末端结构域的稳定版本。将来自 TbpA 的插头和桶结构域的四个表面区域移植到这个 TbpB C 叶支架上,生成稳定的杂交抗原。针对杂交抗原在 表面上的 TbpA,用小鼠和兔产生的抗血清进行了识别,并以与针对天然 TbpA 蛋白的抗血清相当或更好的水平抑制了转铁蛋白依赖性生长。针对两种工程化的杂交抗原,每种抗原都引发了与 TbpA 诱导的相当的 TbpA 特异性杀菌抗体反应。使用外来支架(来自猪病原体 的 TbpB)生成的杂交抗原在 下生殖道定植模型和侵袭性感染模型中进行了评估。loop10 杂交抗原在消除女性小鼠下生殖道中的 和抵抗低剂量侵袭性感染方面与全长 TbpA 一样有效。这些结果表明,TbpB 或其衍生物可以作为展示完整外膜抗原表面表位的有效支架,并且这些抗原可以引发针对细菌挑战的保护。